SBFM FY 2013 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$475,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-827.19

Cash Flow

Operating Cash Flow

-$564,398

Free Cash Flow

-$564,398

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$31,240

Total Liabilities

$38,950

Stockholders' Equity

-$7,710

Cash & Equivalents

$31,240

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$475,000	-$250,000	-90.0%
Operating Income	-$2M	-$706,680	-174.0%
Net Income	-$2M	-$707,952	-251.9%